Midgard
ZP

Zonsen PepLib Biotech Inc.

ZhuZhou, China peplib.com From their website, Nov 2026

Work here? Claim this listing

About

Zonsen PepLib Biotech Inc. is a biotechnology company focused on discovering and developing peptide-based therapeutics. It is headquartered in Zhuzhou, China, with operations in Changsha, China, and a subsidiary in New Jersey, USA. Its work centers on oncology and cardiometabolic diseases and supports multiple peptide-based modalities.

Services

  • Peptide-radionuclide conjugate (PRC) discovery and development

    Supports PRC peptide screening and design, in-vitro study, in-vivo study, and IIT study collaboration.

  • Peptide screening and design

    Uses DRP-PD, AI, mRNA display, and med-chem for PRC-peptide screening and design.

  • Medicinal chemistry optimization

    Optimizes hits to leads for peptide-radionuclide conjugate development.

  • High-throughput screening assay

    Provides high-throughput screening support for peptide discovery programs.

  • Protein expression and purification

    Offers protein expression and purification capability as a technology platform.

    Protein production

  • Cell-line generation

    Provides cell-line generation for research and development work.

  • Gene construction and peptide expression

    Supports gene construction and peptide expression workflows.

  • In vitro BBB penetration assay

    Offers in vitro blood-brain barrier penetration testing.

5 more services
  • 3D cell generation for pharmacodynamic measurement
  • Peptide-chip array screening
  • Conjugation and linker chemistry optimization
  • Computational structural analysis and bioinformatics
  • ADME Met-ID
Turnaround
2-4 months

Capabilities

Assays and studies
  • Peptides
  • Oligonucleotides
  • mRNA
  • HTS
  • ADME
  • High-throughput screening
7 more
  • In-vitro study
  • In-vivo study
  • IIT study
  • BBB penetration assay
  • Peptide-chip array screening
  • ADME Met-ID
  • Pharmacodynamic measurement
Scale and capacity
  • Nearly 500 million peptides in the database
  • More than 300 people
Therapeutic areas
  • Oncology
  • Cardiometabolic diseases

Instruments and platforms

  • AI Platform

Modalities and species

Modalities
  • Peptide
  • Oligonucleotide
  • mRNA
Species and models
  • mRNA Display
  • DRP-PD Library
  • 3D cell

Company

Founded
2017
Team
More than 300 people
Quality
PCT applications

Locations

Address
1769 Yunlong Avenue, Yunlong Demonstration Zone, Zhuzhou, Hunan Province Submit Message C
Sites
  • Changsha, China
  • New Jersey, USA
  • Metuchen, NJ, USA
Serves
Worldwide, China

Similar labs